Research progress in drug repurposing in the treatment of breast cancer

Breast cancer has become one of the most prevalent cancers among women worldwide, posing a significant burden on their health. Current standard therapies are often expensive and associated with the risk of drug resistance. Drug repurposing has gained increasing attention as a cost-effective and time...

Full description

Saved in:
Bibliographic Details
Main Authors: TAN Chen, XU Zhangrun, XUE Yang, CHEN Jiayu, YAO Lijun
Format: Article
Language:zho
Published: Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science) 2024-11-01
Series:Shanghai Jiaotong Daxue xuebao. Yixue ban
Subjects:
Online Access:https://xuebao.shsmu.edu.cn/article/2024/1674-8115/1674-8115-2024-44-11-1454.shtml
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846116410819870720
author TAN Chen
XU Zhangrun
XUE Yang
CHEN Jiayu
YAO Lijun
author_facet TAN Chen
XU Zhangrun
XUE Yang
CHEN Jiayu
YAO Lijun
author_sort TAN Chen
collection DOAJ
description Breast cancer has become one of the most prevalent cancers among women worldwide, posing a significant burden on their health. Current standard therapies are often expensive and associated with the risk of drug resistance. Drug repurposing has gained increasing attention as a cost-effective and time-saving strategy in pharmaceutical research. Many drugs already in clinical use or undergoing clinical trials can be repurposed for the treatment of new clinical indications. Based on a comprehensive understanding of the mechanisms of action of these drugs and the pathophysiological processes of breast cancer, researchers can better identify drugs with potential anti-breast cancer properties and translate them into clinical practice. This paper provides a review of the current research on repurposing existing drugs for breast cancer treatment, summarizes the mechanisms of action of these drugs, and discusses the challenges associated with the strategy of drug repurposing.
format Article
id doaj-art-af63d73ff35b4075a959382d54af2549
institution Kabale University
issn 1674-8115
language zho
publishDate 2024-11-01
publisher Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science)
record_format Article
series Shanghai Jiaotong Daxue xuebao. Yixue ban
spelling doaj-art-af63d73ff35b4075a959382d54af25492024-12-19T02:09:02ZzhoEditorial Office of Journal of Shanghai Jiao Tong University (Medical Science)Shanghai Jiaotong Daxue xuebao. Yixue ban1674-81152024-11-0144111454145910.3969/j.issn.1674-8115.2024.11.0131674-8115(2024)11-1454-06Research progress in drug repurposing in the treatment of breast cancerTAN Chen0XU Zhangrun1XUE Yang2CHEN Jiayu3YAO Lijun4Department of Orthopedics, Shanghai Sixth People′s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200030, ChinaLaboratory of Molecular Biology, Shanghai Jiao Tong University School of Medicine, Shanghai200025, ChinaDepartment of Clinical Laboratory, Shanghai Sixth People′s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200030, ChinaDepartment of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200011, ChinaDepartment of Endocrinology and Metabolism, Shanghai Sixth People′s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200030, ChinaBreast cancer has become one of the most prevalent cancers among women worldwide, posing a significant burden on their health. Current standard therapies are often expensive and associated with the risk of drug resistance. Drug repurposing has gained increasing attention as a cost-effective and time-saving strategy in pharmaceutical research. Many drugs already in clinical use or undergoing clinical trials can be repurposed for the treatment of new clinical indications. Based on a comprehensive understanding of the mechanisms of action of these drugs and the pathophysiological processes of breast cancer, researchers can better identify drugs with potential anti-breast cancer properties and translate them into clinical practice. This paper provides a review of the current research on repurposing existing drugs for breast cancer treatment, summarizes the mechanisms of action of these drugs, and discusses the challenges associated with the strategy of drug repurposing.https://xuebao.shsmu.edu.cn/article/2024/1674-8115/1674-8115-2024-44-11-1454.shtmldrug repurposingbreast cancerchemotherapyanti-tumor
spellingShingle TAN Chen
XU Zhangrun
XUE Yang
CHEN Jiayu
YAO Lijun
Research progress in drug repurposing in the treatment of breast cancer
Shanghai Jiaotong Daxue xuebao. Yixue ban
drug repurposing
breast cancer
chemotherapy
anti-tumor
title Research progress in drug repurposing in the treatment of breast cancer
title_full Research progress in drug repurposing in the treatment of breast cancer
title_fullStr Research progress in drug repurposing in the treatment of breast cancer
title_full_unstemmed Research progress in drug repurposing in the treatment of breast cancer
title_short Research progress in drug repurposing in the treatment of breast cancer
title_sort research progress in drug repurposing in the treatment of breast cancer
topic drug repurposing
breast cancer
chemotherapy
anti-tumor
url https://xuebao.shsmu.edu.cn/article/2024/1674-8115/1674-8115-2024-44-11-1454.shtml
work_keys_str_mv AT tanchen researchprogressindrugrepurposinginthetreatmentofbreastcancer
AT xuzhangrun researchprogressindrugrepurposinginthetreatmentofbreastcancer
AT xueyang researchprogressindrugrepurposinginthetreatmentofbreastcancer
AT chenjiayu researchprogressindrugrepurposinginthetreatmentofbreastcancer
AT yaolijun researchprogressindrugrepurposinginthetreatmentofbreastcancer